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Theneurotrophin brain-derived neurotrophic factor (BDNF) inhibits Schwann cell (SC)migration andpromotesmyelination via the p75
neurotrophin receptor (NTR). Despite these recent findings, the expression, localization, and mechanism of BDNF action has yet to be
determined. Here we demonstrate that the sensory neurons of the dorsal root ganglion (DRG) are a major source of BDNF during
postnatal development. The expression of BDNF is initially elevated before myelination and decreases dramatically after the onset of
myelination. BDNF expression is controlled in part by transcriptional regulation and the increased expression of the truncated TrkB
receptor on SCs. To investigate the possible mechanism of BDNF transport and release, multicompartment Campenot chambers were
used. DRG neurons transported and secreted endogenous BDNF along the surface of axons in anterograde fashion. In an attempt to
enhance myelination by SCs, DRG neurons were transduced with an adenovirus to overexpress BDNF. BDNF was transported and
secreted along the axons and enhanced myelination when compared with control cocultures. Together, the events surrounding the
expression, localization, and mechanism of BDNF action in DRG neurons may hint at potential therapeutic implications to efficiently
promote remyelination.
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Introduction
The complex interplay between glia and neurons is essential for
the development and function of the nervous system. Schwann
cell (SC) proliferation, migration, and myelination are undoubt-
edly controlled by signals that are directed from the neuron.Neu-
rotrophins, a family of growth factors initially found to be critical
for neuronal survival and outgrowth (Huang and Reichardt,
2001), have been implicated recently as key factors involved in SC
development (Hempstead, 2005). Specifically, brain-derived
neurotrophic factor (BDNF) was shown to enhance myelination
in SCs through p75NTR and to subsequently inhibit migration
through the RhoA/Rho kinase pathway (Cosgaya et al., 2002;
Yamauchi et al., 2004). On the contrary, neurotrophin 3 (NT3)
signaling in SCs enhanced cell migration and inhibited myelin
formation via the full-length TrkC receptor (Cosgaya et al., 2002;
Yamauchi et al., 2003). The temporal relationship between NT3
and BDNF signaling was examined in vitro. NT3 levels were ele-
vated during SC proliferation and migration and decreased dur-
ing myelination, whereas BDNF levels remained elevated
throughout (Cosgaya et al., 2002). The results of these experi-
ments have begun to shed light on the important yet distinct roles
that neurotrophins play during peripheral nerve development.
Although the function of BDNFduringmyelination is becom-
ing more apparent, it is still not clear which cell type produces
BDNF or how it is being transported. If the expression of BDNF
can be localized during myelination, will focal overexpression
augment the myelination process and provide a more efficient
therapeutic approach in cases of demyelination? Recent evidence
points to the expression of BDNF in neurons and secretion at
nerve terminals that are most likely in contact with target tissues
(Barakat-Walter, 1996; Tonra, 1999; Lessmann et al., 2003). This
suggests that BDNF is transported in anterograde fashion. How-
ever, because SCs do not myelinate nerve terminals, could BDNF
also be secreted along the axon? Additionally, it is also quite pos-
sible that BDNF is secreted by SCs, activating p75NTR in an auto-
crinemanner (Friedman et al., 1999; Esper and Loeb, 2004).Here
we demonstrate that sensory neurons of the dorsal root ganglion
(DRG) are a major source of BDNF during postnatal develop-
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ment when compared with SCs. DRG neurons secrete endoge-
nous BDNF along their axons in anterograde fashion to promote
SC myelination. The expression and secretion of BDNF by DRG
neurons is dynamically regulated at both the transcriptional level
and by the induction of the truncated TrkB/T1 receptor. Addi-
tionally, adenoviral-mediated overexpression of BDNF in DRG
neurons significantly enhances myelination by SCs in coculture.
The overexpression and presentation of BDNF as outlined in this
study may give rise to future experiments that assess whether
remyelination can be achieved through the localized delivery of
BDNF after demyelination attributable to injury or disease.
Materials andMethods
Primary cell culture. Purified DRG neurons and SCs were established
usingmethods described byKleitman et al. (1998) andChan et al. (2004).
Briefly, DRG neurons from embryonic day 15 Sprague Dawley rats were
dissociated, plated, and purified on collagen-coated coverslips in the
presence of NGF (100 ng/ml). Neurons were purified before addition of
SCs. Myelination was initiated with the addition of ascorbic acid (50
g/ml).
Campenot chambers. The compartmentalized Campenot chambers
were prepared as described previously (Campenot, 1992; Chan et al.,
2004).DRGneuronswere plated into the side compartment of the cham-
ber, and axons were allowed to grow into the second and third compart-
ment in the presence of NGF. Antimitotic mediumwas used to eliminate
non-neuronal cells. The integrity of the seal between compartments was
tested quantitatively throughout the experiment by monitoring the abil-
ity of phenol red to diffuse to phenol red-free compartments.
Adenovirus production and infection of DRG neurons. cDNA for the
myc-tagged BDNF was subcloned into pAdTrackCMV for the genera-
tion of recombinant adenovirus (pAdEasy system) (He et al., 1998;Wu et
al., 2004). myc–BDNFwas subcloned with SalI and XbaI, and large-scale
virus preparationswere performed in human embryonic kidneyHEK293
cells using the cesium chloride banding method. Adenovirus titers were
determined as described previously (Graham and Prevec, 1995). Subse-
quently, purified recombinant adenovirus was added directly to the neu-
rons at a multiplicity of infection of 10.
Competitive reverse transcription-PCR. Competitive reverse transcrip-
tion (RT)-PCR was performed for the ribosomal protein L19 (internal
control) and BDNF using methods as described by Friedman et al.
(1996). The competitors for L19 and BDNF were PCR amplified from a
rat sciatic nerve cDNA library with an internal 30 nt deletion and cloned
into the pGEM-T vector using theQuickChange Site-DirectedMutagen-
esis kit (Stratagene, La Jolla, CA). The RNA from sciatic nerves, spinal
cords, and cocultures were extracted using the TRIZOL reagent (Invitro-
gen, Carlsbad, CA). Reverse transcription was performed with 8 g of
total RNA after DNase I (GEHealthcare, Little Chalfont, UK) treatment.
The PCR reactions included 40 ng of RNA from the RT reactions for the
different samples and a series of dilutions for the L19 and BDNF com-
petitors. Each sample consisted of at least seven different concentrations
of competitor. Quantification was achieved using the NIH Image 1.62
software and by performing a linear regression of log (competitor/gene
of interest) with log (concentration of the competitor). The point at
which log (competitor/gene of interest) is zero is the equivalence point;
the antilog gives the concentration of the gene of interest. The SE of
estimate was calculated from the regression model of each sample.
BDNF ELISA. ELISAs were performed using the TMB (tetramethyl-
benzidine) Peroxidase Substrate System (KPL, Gaithersburg, MD), as
described previously (Kruttgen et al., 1998; Chan et al., 2001). Briefly, the
BDNF ELISA was accomplished using the TrkB–Fc fusion protein (Re-
generon Pharmaceuticals, Tarrytown, NY) as the capturing reagent, fol-
lowed by incubation of the samples. The BDNF was detected using a
polyclonal chicken anti-BDNF primary antibody followed with an anti-
chicken HRP antibody (Promega, Madison, WI). The substrate was in-
cubated for 2–5 min or until adequate signal was detected. ELISA
reactions were stopped with the addition of 1 M phosphoric acid.
Western blot analysis. Samples from primary cultures were prepared
forWestern blot as described previously (Chan et al., 2004). The proteins
were transferred to pure nitrocellulosemembranes and probed with spe-
cific antibodies. p75NTR, TrkB/T1, and TrkA were probed with rabbit
antibodies against each specific neurotrophin receptor [anti-p75NTR
(Promega), anti-TrkB (Transduction Laboratories, Lexington, KY), and
anti-TrkA (gift from Louis F. Reichardt, University of California, San
Francisco, CA)]. Mouse antibodies against myelin associated glycopro-
tein (MAG) and P0, were used to identify the extent ofmyelination in the
cultures [anti-MAG (Chemicon, Temecula, CA) and anti-P0 (from Juan
J. Archelos, Karl-Franzen-Universitat, Graz, Austria)]. Additionally, an
antibody against -actin (Sigma, St. Louis, MO) was used as a loading
control. Blots were typically stripped and reprobed.
Immunostaining. Immunostaining of SC/DRG cocultures was per-
formed as described previously (Chan et al., 2004). Briefly, cultures were
washed and fixed using 4% paraformaldehyde and then permeabilized
and blocked by incubation with 20% goat serum and 0.2% Triton X-100
in PBS.Myelin was visualized with a rat anti-myelin basic protein (MBP)
antibody (Chemicon), followed by incubation of secondary antibodies.
SCs were visualized with a rabbit anti-S100 antibody (DakoCytoma-
tion, High Wycombe, UK) and DRG neurons with a mouse anti-
neurofilament antibody (American Type Culture Collection, Manassas,
VA). myc-tagged BDNF was detected with a mouse anti-myc antibody
(Santa Cruz Biotechnology, Santa Cruz, CA). Cellular nuclei were exam-
ined with 4,6-diamidino-2-phenylindole (DAPI).
In situ hybridization. In situ hybridization was performed as described
previously (Frantz et al., 1994). SC/DRG cocultures were grown on
chamber slides and fixed in 4%paraformaldehyde for 15min. Slideswere
rinsed in PBS, dehydrated, and stored at 80°C. 35S-labeled bdnf anti-
sense and sense riboprobes were transcribed from linearized pGEMT
plasmid containing bdnf cDNA. Briefly, slides were pretreated with pro-
teinase K (3.7g/ml), digestion, and acetylation. After overnight hybrid-
ization at 60°C, slideswere treatedwith ribonuclease A (5g/ml) at 37°C.
After a high-stringency wash in 0.1 SSC at 60°C, slides were dehydrated
in an ethanol and xylene gradient and thoroughly air dried. Slides were
then dipped in Eastman Kodak (Rochester, NY) NTB2 autoradiographic
emulsion and exposed for 3weeks before developing. After development,
slides were counterstained with cresyl violet and visualized.
Adenoviral transduction of DRGs at L4/L5 in postnatal rats. myc–
BDNF/green fluorescent protein (GFP) or GFP virus (2l) were injected
into the ipsilateral or contralateral DRGs of 7-d-old SpragueDawley rats,
respectively. Briefly, rats were anesthetized with xylazine/ketamine. The
dorsal surface of L4 and L5 DRGs were exposed by performing a double
laminectomy, and virus was injected into the DRG at a rate of1l/min
using a 10 ml Hamilton microsyringe fitted with a sterile pulled glass
micropipette by inserting the tip into the ganglion. Muscle layers were
sutured, and the skin was secured with wound clips. The rats were placed
on soft bedding on a warming blanket held at 37°C for 3 h after surgery.
Seven days later, rats were killed and perfused transcardially with 4%
paraformaldehyde in 0.1 M PBS, pH 7.4. DRGs and sciatic nerves were
isolated and prepared for immunohistochemistry as described previ-
ously (Glatzel et al., 2000).
Results
BDNF expression is localized to DRG neurons and is
developmentally regulated
The expression of BDNF was initially examined using competi-
tive RT-PCR on purified SCs, DRGneurons, and SC/DRG cocul-
tures. The coculture system is instrumental for the observation of
various stages preceding, during, and after active myelination.
BDNFmRNA levels were normalized and expressed as a percent-
age of the ribosomal protein L19 (internal control) fromSC/DRG
cocultures at various time points throughout myelination (Fig.
1A). An increase in BDNF mRNA expression was observed
shortly after purified SCs were seeded onto DRG neurons. This
elevated expression was followed by a gradual decrease in BDNF
mRNA throughout active myelination. Additionally, the expres-
sion of BDNF protein secreted by purified SCs, DRG neurons,
and cocultures was also measured by ELISA. Consistent with the
7598 • J. Neurosci., July 11, 2007 • 27(28):7597–7603 Ng et al. • Axonal BDNF Promotes Myelination
mRNA expression profile, purified DRG neurons cultured alone
secreted significant amounts of BDNF (Fig. 1B). AlthoughBDNF
transcript was detected in purified SCs by RT-PCR, BDNF pro-
tein could not be detected by ELISA. Premyelinating cocultures
secreted the highest amount of BDNF, decreasing throughout the
course of active myelination. After 6 d of induction with ascorbic
acid, BDNF levels were undetectable in the coculture medium
(0.02 ng/ml). However, the BDNFmRNA levels suggest a grad-
ual decrease in BDNF expression even at these later time points in
the cocultures. Immunoblot analysis of parallel coculture lysates
revealed a possible alternative regulatory mechanism for BDNF
with the induction of the TrkB/T1 receptor on SCs. This induc-
tion coincides with the decrease in the level of secreted BDNF
(Fig. 1B). This is consistent with previous findings that illustrate
a dramatic decrease in secreted BDNF levels during active myeli-
nation, indicative of BDNF depletion by TrkB/T1 (Cosgaya et al.,
2002). The expression of the myelin proteins P0 and MAG indi-
cate that the initiation of myelination occurs between 2 and 4 d
after induction. To determine the localization and production of
BDNF, premyelinating cocultures were analyzed for BDNF
mRNA using in situ hybridization. BDNF transcripts were pri-
marily localized in DRG neurons as evidenced by intense radio-
active labeling of the cell soma (Fig. 1D, arrows, right). Under
bright-field microscopy, a counterstain
with cresyl violet revealed SCs occupying
the field (Fig. 1D, arrowheads, left), but
they accounted for little to none of the ra-
dioactivity present.
It must be noted that BDNF transcript is
detected in purified SCs byRT-PCR and not
by in situ hybridization or ELISA. This dis-
crepancy is very likely attributed to differ-
ences between purified cells and cocultures.
In an attempt to determine the expression of
BDNF in vivo, rat sciatic nerves and the
L4/L5 DRGs were examined using competi-
tiveRT-PCR.ThemRNAfromsciaticnerves
and L4/L5 DRGs were extracted at various
time points during postnatal development.
BDNFmRNA levels in the sciatic nervewere
found to be negligible as a percentage of the
internal control and significantly lower than
in the DRG (Fig. 1E,F). BDNF transcripts
were 1000-fold higher in the DRG when
compared with sciatic nerves. Additionally,
the expression of P0, MAG, TrkB/T1, and
p75NTRwere analyzed by immunoblot anal-
ysis and were consistent with the expression
in the cocultures. The similarity in the tem-
poral expression of TrkB/T1 and the initia-
tion of myelination seemed to suggest a
common developmental mechanism found
both in vitro and in vivo (Fig. 1G). Together,
our results demonstrate that the sensory
neurons of the DRG are a major source of
BDNF during postnatal development. The
expression of BDNF is initially elevated be-
fore myelination and decreases dramatically
after theonsetofmyelination.BDNFexpres-
sion is controlled in part by transcriptional
regulation and the increased expression of
TrkB/T1 on SCs.
Endogenous BDNF is transported in anterograde fashion and
secreted along axons
To determine the mechanism of transport and secretion of en-
dogenous BDNF, multicompartment Campenot chambers were
used to physically separate the neuronal cell bodies from their
axons and nerve terminals. As illustrated in Figure 2A, DRG
neuronal cell bodies (soma) were typically cultured in the side
compartment, whereas axons were directed to grow underneath
the barriers and into the proximal and distal compartments. As a
result, the middle compartment contained mainly axons,
whereas the distal compartment contained axons and their ter-
minals. DRG neurons were cultured for 2–3 weeks within the
chambers to allow for growth and purification. The integrity of
the barriers was continuously tested to eliminate the possibility of
soluble factors flowing between compartments. This was
achieved by quantitativelymonitoring the ability of phenol red in
the somal compartment to diffuse to the phenol red-free axonal
compartments.Medium collected every 3 dwasmeasured for the
absorption of phenol red at 560 nm, with any absorbance from
the axonal compartments indicating leakage (Fig. 2C). Only
those chambers that displayed both significant axon growth into
the second and third compartments and had no signs of leakage
were further analyzed.Medium taken from the somal and axonal
Figure 1. Expression and localization of BDNF during development. A, mRNA was extracted from SCs, DRG neurons, and
premyelinatingDRG/SC cocultures at the indicated days after induction ofmyelinationwith ascorbic acid. BDNFmRNA levelswere
analyzed by competitive RT-PCR and expressed as a percentage of the L19 ribosomal proteinmRNA.B, Conditionedmediumwas
collected from purified SCs, DRG neurons, and premyelinating and myelinating cocultures and analyzed by ELISA. The medium
fromtheSCs andDRGneuronswas collected throughout theentire lengthof theexperiment. BDNF levels belowdetection limit are
indicated by asterisks. Values represent themean SD concentration of BDNF from three separate cocultures, eachmeasured in
triplicate. C, Immunoblot analysis was performed for P0, MAG, TrkB/T1, and p75
NTR from parallel cocultures. D, Localization of
BDNF mRNA was accomplished through the use of radioactive in situ hybridization. Premyelinating cocultures were counter-
stained with cresyl violet to visualize the SCs (arrowheads) and DRG neuronal cell bodies (arrows) under bright-field microscopy
(left). Visualization of the probewas accomplished by autoradiography using liquid emulsion anddark-fieldmicroscopy (right). E,
F, mRNA transcripts isolated from rat sciatic nerve and L4/L5 DRG were subjected to competitive RT-PCR to measure temporal
expression levels of endogenousBDNF. Sciatic nerve andDRG sampleswere taken frompostnatal rats as indicated.G, Immunoblot
analysis was performed for P0, MAG, TrkB/T1, and p75
NTR from rat sciatic nerve extracts at the indicated postnatal days.
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compartments were assayed for BDNF by ELISA (Fig. 2B). In
addition to significant amounts of BDNF secreted in the DRG
somal compartment, a comparable amount was detected in the
axonal compartment. On average, 0.15 ng/ml BDNF was de-
tected in either compartment. The BDNF concentrations be-
tween the two compartments were not significantly different as
determined by Student’s t test. Results from this assay indicate
that BDNF is not only secreted from neuronal cell bodies but is
also anterogradely transported and secreted along the surface of
the axon.
Adenoviral-mediated overexpression of BDNF in DRG
neurons enhances SC myelination
Myc-tagged BDNF adenoviral constructs, which were coex-
pressed with GFP, were designed to overexpress BDNF in DRG
neuron cultures. Approximately 1 week after infection, DRG
neurons were fixed and stained with an anti-myc antibody (Fig.
3Ab,Ad). Parallel neuronal cultures infectedwith aGFP construct
were similarly immunostained (Fig. 3Bb,Bd). Adenoviral-
mediated infection of primary neuronal cultures was achieved at
high efficiency (80%). All experimental cultures were exten-
sively populated with GFP-expressing axons. Neurons that were
infected with the myc–BDNF construct also showed distinct myc
immunoreactivity in cell bodies and along axonal tracts (Fig.
3Ab,Ad). Minimal myc immunoreactivity was seen in cultures
infected with the GFP construct alone (Fig. 3Bb,Bd). Approxi-
mately 1 week after infection, DRG neuronal cultures were
seeded with purified SCs to gauge the effects of BDNF overex-
pression on myelin formation. BDNF expression was examined
by ELISA (Fig. 3C). Secreted BDNF levels from the myc–BDNF-
infected DRG neuronal cultures were70-fold greater than en-
dogenous BDNF levels from the GFP-infected cultures (Fig. 3D).
A similar increase was observed in the SC/DRG neuronal cocul-
tures during premyelinating periods. Surprisingly, a dramatic de-
crease in BDNF expression was detected even in themyc–BDNF-
infected cultures after 4 d of induction, in a similarmanner to the
GFP-infected cocultures (Fig. 3C,D). After 10 d of induction,
cocultures were immunostained with an anti-MBP antibody to
visualize the extent of myelin formation in the infected cocul-
tures. Myelination of the myc–BDNF-infected neurons was ap-
proximately fivefold greater when counting the percentage of
myelinating Schwann cells per field compared with GFP-infected
cultures (Fig. 3E–G).
myc–BDNF is transported in an anterograde manner and
secreted along DRG axons to promote Schwann cell
myelination
Campenot chambers were also used to determine the method of
BDNF delivery to SCs. DRG neuronal cell bodies cultured in
Campenot chambers were infected with either themyc–BDNF or
the GFP adenoviral construct as described previously. The ade-
novirus was removed after overnight infection, and the neurons
were cultured for 1 week before SCs were seeded into the center
axonal compartment (Fig. 4A). Three days after seeding, the co-
cultures were stained with an anti-myc antibody (Fig. 4B). In the
cocultures with myc–BDNF-infected neurons, myc immunore-
activity (red) was seen in almost all SCs that had aligned or were
in direct contact with GFP-positive axons. This was indicative of
secretion and transfer of myc–BDNF from the axon to the SC.
Myc immunoreactivity was minimal in control cocultures with
GFP-only infected neurons. On closer inspection ofmyc-positive
SCs, transfer of myc–BDNF was clearly evident by intense myc
immunoreactivity in the SC body (Fig. 4C). SCs were clearly
identified by S100 immunoreactivity (blue). myc-positive SCs
were not GFP positive from aberrant adenoviral infection. In
parallel cocultures, medium from the DRG somal and axonal
compartments were assayed for BDNF secretion 8 d after induc-
tion of myelination. Both compartments contained high levels of
secreted BDNF in the infected neurons (Fig. 4D). Approximately
100 ng/ml BDNF was detected in the somal compartments,
whereas up to 20 ng/ml BDNF was detected in the axonal com-
partments. Comparatively lower amounts of endogenous BDNF
(0.2 ng/ml)were detected in theDRG somal compartments of the
GFP-infected neurons. Virtually no BDNF was detected in the
axonal compartments, illustrating once again the dramatic de-
crease in BDNF protein levels during activemyelination (Chan et
al., 2001). The infected cocultures were then analyzed for myelin
formation in the center compartments byMBP immunostaining
and quantification. Cocultures infected with the myc–BDNF ad-
enovirus had threefold more myelin internodes than the GFP-
infected cocultures (Fig. 4E).
Discussion
Various mechanisms have been proposed that describe the ex-
pression and transport of neurotrophins in the nervous system.
Traditionally, neurotrophins have been described as “target-
derived” signaling molecules, influencing the growth and sur-
vival of innervating neurons (Lessmann et al., 2003). This sug-
gests that target tissues express and secrete neurotrophins,
whereby they are internalized by axon terminals and activate sig-
naling pathways in neuronal cell bodies after retrograde transport
(Howe and Mobley, 2005; Zweifel et al., 2005). In certain cases,
neurotrophins can also be expressed by neurons and act by an-
terograde transportmechanisms (Zhou andRush, 1996; Tonra et
al., 1998). Double ligation of rat sciatic nerves results in the ac-
Figure 2. Endogenous BDNF is transported and secreted from DRG neuronal axons. A, DRG
neurons cultured in Campenot chambers were established as illustrated. The center compart-
ment contains axons, whereas the distal compartment contains both axons and nerve termi-
nals.B, Conditionedmedium taken from theDRG somal andmiddle axonal compartmentswere
analyzedbyELISA for BDNF. Values represent themeanSD concentrationofBDNF fromseven
separate chambers.C, The integrity of the chamber barrierswas continuously tested from seven
different chambers to eliminate the possibility of soluble factors flowing between compart-
ments. This was achieved by quantitatively monitoring the ability of phenol red in the somal
compartment to diffuse to the phenol red-free axonal compartments.
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cumulation of BDNF both proximally and distally to the ligated
segment, illustrating both anterograde and retrograde transport,
respectively (Zhou and Rush, 1996). It has also been suggested
that local protein synthesis can contribute to the axonal protein
pool. Although it is possible that BDNF is locally synthesized in
the axons, studies illustrate an upregulation in axonal protein
synthesis only after nerve transection (Zheng et al., 2001). Addi-
tionally, in intact nerves, ribosomes are typically found in high
abundance at the initial axonal segments near the DRG (Pannese
and Ledda, 1991). Concurrent to the results shown in this study,
in vivo experiments demonstrate that the initial overexpression of
myc–BDNF/GFP in L4 and L5DRGneurons can later be detected
in corresponding axons of the sciatic nerve
(supplemental Fig. 1, available at www.j-
neurosci.org as supplemental material).
The expression of BDNF in the sciatic
nerve provides additional support for its
anterograde transport from the cell body.
Together, sensory neurons produce and
transport BDNF in an anterograde man-
ner to axon terminals in which either au-
tocrine or paracrine pathways are initiated
through TrkB and/or p75NTR. However,
because SCs do notmyelinate nerve termi-
nals, could BDNF be secreted along the
surface of the axon? This is an issue that
has not been thoroughly examined be-
cause of a lack of functional significance.
We propose that the process of myeli-
nation requires direct signaling from the
axon. Recent evidence has pointed to the
importance of axonal signaling in SC my-
elination with the finding that axonal
neuregulin-1 type III encodes for a physi-
ological measure of axon size to regulate
the thickness of the myelin sheath
(Michailov et al., 2004; Taveggia et al.,
2005). We demonstrate that the antero-
grade transport and secretion of BDNF
from the neuronal axon enhances myelin
formation by SCs in vitro. Admittedly, our
data does not address the specific activa-
tion of p75NTR on SCs and that BDNFmay
potentially activate p75NTR on sensory ax-
ons. However, our data clearly demon-
strate that BDNF secreted by DRGs is
taken up by SCs. This is consistent with
our recent finding that the polarity protein
Par-3 is enriched at the axon/SC interface
and actively binds and recruits p75NTR in
response to BDNF (Chan et al., 2006).
Previously, a number of different strat-
egies involvingmyelin repair have been re-
ported, including the transplantation of
exogenous cell types that are often engi-
neered to overexpress neurotrophins or
other growth factors. For example, NT3
and BDNF transduced macaque SCs were
grafted into demyelinated spinal cords of
nude mice (Girard et al., 2005). The se-
creted neurotrophins successfully pro-
moted clinical recovery, enhanced oligo-
dendrocyte precursor cell and SC
differentiation, and reduced astrogliosis (Girard et al., 2005;
Tepavcevic and Blakemore, 2005). In other studies, engineered,
native fibroblasts were used to deliver a constant flow of neuro-
trophins to injury sites. Primary rat fibroblasts were infected with
a construct encoding NT3 and grafted into lesioned spinal cords
of adult rats. Increased axonal outgrowth was reported in the
treated spinal cords, but only partial functional recovery was ob-
tained (Grill et al., 1997). Similarly, our data hopes to contribute
tomore efficient and novel therapeutic strategies to achieve func-
tional myelin repair. Our studies demonstrate that sensory neu-
rons of theDRGare amajor source of BDNFduring development
and that increasing BDNF expression in neurons significantly
Figure 3. Overexpression of BDNF in SC/DRG cocultures enhances myelin formation. A, B, Purified DRG neurons were infected
with a myc–BDNF or GFP adenoviral construct for 12 h. Seven days after initial infection, the neurons were visualized for GFP
fluorescence (Aa, Ac, Ba, Bc) and also immunostained with an anti-myc antibody (Ab, Ad, Bb, Bd). Scale bar, 50m. C, D, DRG
neuron cultures infected with a myc–BDNF (C) or GFP (D) were seeded with purified SCs and analyzed for BDNF at various time
points during myelin formation. BDNF levels below detection limit are indicated by asterisks. Values represent the mean SD
concentration of BDNF from three separate cocultures, eachmeasured in triplicate by ELISA. E–G, Myc–BDNF and GFP cocultures
were stained for MBP (red) to measure the extent of myelination after 10 d of induction. An approximate fivefold increase in the
percentage of myelinating Schwann cells was observed in the myc–BDNF-infected cocultures when compared with the GFP-
infected cocultures. Scale bar, 100m. Significance was evaluated using Student’s t test (*p 0.005).
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enhances the number of SC myelin internodes. Although the
experiments presented here were performed in vitro, it is our
hope that these findings may translate to in vivomodels, with the
potential therapeutic role of overexpressing BDNF in sensory
neurons to promote remyelination after nerve injury or demyeli-
nating disease.
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